Vimarsana
Biggest News Aggregation in the World

James Ip News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from James Ip. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In James Ip Today - Breaking & Trending Today

Home-administered nasal spray could be safely used to treat recurrent rapid heart rhythms - Vimarsana News

Home-administered nasal spray could be safely used to treat recurrent rapid heart rhythms

A clinical trial led by Weill Cornell Medicine investigators showed that a nasal spray that patients administer at home, without a physician, successfully and safely treated recurrent episodes of a condition that causes rapid abnormal heart rhythms.

Nasal spray can safely treat recurrent abnormal heart rhythms - Vimarsana News

Nasal spray can safely treat recurrent abnormal heart rhythms

A clinical trial led by Weill Cornell Medicine investigators showed that a nasal spray that patients administer at home, without a physician, successfully and safely treated recurrent episodes of a condition that causes rapid abnormal heart rhythms.

Effective Nasal Spray Therapy for Recurrent Abnormal Heart Rhythms - Vimarsana News

Effective Nasal Spray Therapy for Recurrent Abnormal Heart Rhythms

Etripamil nasal spray, self-administered at home, was found to relieve recurrent rapid abnormal heart rhythms.

Outpace PSVT in 2024 by investing in heart health - Vimarsana News

Outpace PSVT in 2024 by investing in heart health

(BPT) - The holiday season can be a stressful time for many people. Travel, family gatherings, reminders of personal loss and much more can lead to high stress and anxiety

Experts' Perspectives: Top News in Cardiology for 2023 - Vimarsana News

Experts' Perspectives: Top News in Cardiology for 2023

A group of 13 leading experts provides their perspectives on the top news in cardiovascular medicine from 2023, with responses ranging from novel approvals to new semaglutide data to gene therapy and more.